The Cooper Companies, Inc (COO) - Total Assets

Latest as of January 2026: $12.42 Billion USD

Based on the latest financial reports, The Cooper Companies, Inc (COO) holds total assets worth $12.42 Billion USD as of January 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore COO current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

The Cooper Companies, Inc - Total Assets Trend (1985–2025)

This chart illustrates how The Cooper Companies, Inc's total assets have evolved over time, based on quarterly financial data.

The Cooper Companies, Inc - Asset Composition Analysis

Current Asset Composition (October 2025)

The Cooper Companies, Inc's total assets of $12.42 Billion consist of 17.0% current assets and 83.0% non-current assets. Also see COO market cap for the company's overall valuation and market capitalisation.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 0.9%
Accounts Receivable $829.00 Million 6.7%
Inventory $846.00 Million 6.8%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $1.59 Billion 12.8%
Goodwill $3.85 Billion 31.1%

Asset Composition Trend (1985–2025)

This chart illustrates how The Cooper Companies, Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See COO share price today for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: The Cooper Companies, Inc's current assets represent 17.0% of total assets in 2025, a decrease from 63.9% in 1985.
  • Cash Position: Cash and equivalents constituted 0.9% of total assets in 2025, down from 23.0% in 1985.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 43.0% of total assets, an increase from 23.0% in 1985.
  • Asset Diversification: The largest asset category is goodwill at 31.1% of total assets.

The Cooper Companies, Inc Competitors by Total Assets

Key competitors of The Cooper Companies, Inc based on total assets are shown below.

Company Country Total Assets
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
China CN¥12.68 Billion
Kyobo 8 Special Purpose Acquisition Company
KQ:307280
Korea ₩49.65 Billion
Safe Orthopaedics SA
PA:ALSAF
France €7.94 Million
Ansell Ltd
AU:ANN
Australia AU$3.33 Billion
Nanosonics Ltd
AU:NAN
Australia AU$279.25 Million
SDI Ltd
AU:SDI
Australia AU$135.84 Million
Austco Healthcare Ltd
AU:AHC
Australia AU$91.07 Million
Trajan Group Holdings Ltd
AU:TRJ
Australia AU$192.32 Million

The Cooper Companies, Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.34 1.99 1.33
Quick Ratio 0.79 1.14 0.75
Cash Ratio 0.00 0.00 0.00
Working Capital $538.10 Million $987.40 Million $329.90 Million

The Cooper Companies, Inc - Advanced Valuation Insights

This section examines the relationship between The Cooper Companies, Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.40
Latest Market Cap to Assets Ratio 0.94
Asset Growth Rate (YoY) 0.6%
Total Assets $12.39 Billion
Market Capitalization $11.71 Billion USD

Valuation Analysis

Near Book Valuation: The market values The Cooper Companies, Inc's assets close to their book value (0.94x), suggesting investors view the company's assets at approximately fair value.

Positive Asset Growth: The Cooper Companies, Inc's assets grew by 0.6% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for The Cooper Companies, Inc (1985–2025)

The table below shows the annual total assets of The Cooper Companies, Inc from 1985 to 2025.

Year Total Assets Change
2025-10-31 $12.39 Billion +0.65%
2024-10-31 $12.32 Billion +5.63%
2023-10-31 $11.66 Billion +1.45%
2022-10-31 $11.49 Billion +19.63%
2021-10-31 $9.61 Billion +42.58%
2020-10-31 $6.74 Billion +7.38%
2019-10-31 $6.27 Billion +2.65%
2018-10-31 $6.11 Billion +25.81%
2017-10-31 $4.86 Billion +8.55%
2016-10-31 $4.48 Billion +0.34%
2015-10-31 $4.46 Billion +0.05%
2014-10-31 $4.46 Billion +42.11%
2013-10-31 $3.14 Billion +6.66%
2012-10-31 $2.94 Billion +12.07%
2011-10-31 $2.62 Billion +3.94%
2010-10-31 $2.53 Billion -1.05%
2009-10-31 $2.55 Billion -1.38%
2008-10-31 $2.59 Billion +1.07%
2007-10-31 $2.56 Billion +8.83%
2006-10-31 $2.35 Billion +7.93%
2005-10-31 $2.18 Billion +168.60%
2004-10-31 $811.56 Million +15.02%
2003-10-31 $705.56 Million +23.54%
2002-10-31 $571.12 Million +43.91%
2001-10-31 $396.85 Million +23.03%
2000-10-31 $322.56 Million +12.82%
1999-10-31 $285.90 Million -3.41%
1998-10-31 $296.00 Million +68.85%
1997-10-31 $175.30 Million +70.36%
1996-10-31 $102.90 Million +11.85%
1995-10-31 $92.00 Million -3.26%
1994-10-31 $95.10 Million -13.15%
1993-10-31 $109.50 Million -37.03%
1992-10-31 $173.90 Million -7.30%
1991-10-31 $187.60 Million -13.71%
1990-10-31 $217.40 Million -24.51%
1989-10-31 $288.00 Million -74.68%
1988-10-31 $1.14 Billion -16.22%
1987-10-31 $1.36 Billion +59.48%
1986-10-31 $851.40 Million +56.05%
1985-10-31 $545.60 Million --

About The Cooper Companies, Inc

NASDAQ:COO USA Medical Instruments & Supplies
Market Cap
$14.89 Billion
Market Cap Rank
#1994 Global
#743 in USA
Share Price
$76.32
Change (1 day)
+2.82%
52-Week Range
$58.98 - $84.32
All Time High
$113.94
About

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and wome… Read more